A citation-based method for searching scientific literature

K Ogurtsova, J D da Rocha Fernandes, Y Huang, U Linnenkamp, L Guariguata, N H Cho, D Cavan, J E Shaw, L E Makaroff. Diabetes Res Clin Pract 2017
Times Cited: 1645







List of co-cited articles
129 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
8

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.
N H Cho, J E Shaw, S Karuranga, Y Huang, J D da Rocha Fernandes, A W Ohlrogge, B Malanda. Diabetes Res Clin Pract 2018
8

Global estimates of diabetes prevalence for 2013 and projections for 2035.
L Guariguata, D R Whiting, I Hambleton, J Beagley, U Linnenkamp, J E Shaw. Diabetes Res Clin Pract 2014
5

Diabetic retinopathy.
Ning Cheung, Paul Mitchell, Tien Yin Wong. Lancet 2010
5

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
5

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
5

Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.
Yan Zheng, Sylvia H Ley, Frank B Hu. Nat Rev Endocrinol 2018
5

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.
Sarah Wild, Gojka Roglic, Anders Green, Richard Sicree, Hilary King. Diabetes Care 2004
5

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
4

Oxidative stress and diabetic complications.
Ferdinando Giacco, Michael Brownlee. Circ Res 2010
4



Advanced glycation end products and diabetic complications.
Varun Parkash Singh, Anjana Bali, Nirmal Singh, Amteshwar Singh Jaggi. Korean J Physiol Pharmacol 2014
613
3

Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030.
Christian Bommer, Vera Sagalova, Esther Heesemann, Jennifer Manne-Goehler, Rifat Atun, Till Bärnighausen, Justine Davies, Sebastian Vollmer. Diabetes Care 2018
317
3

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
3

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
William C Knowler, Elizabeth Barrett-Connor, Sarah E Fowler, Richard F Hamman, John M Lachin, Elizabeth A Walker, David M Nathan. N Engl J Med 2002
3


Global trends in diabetes complications: a review of current evidence.
Jessica L Harding, Meda E Pavkov, Dianna J Magliano, Jonathan E Shaw, Edward W Gregg. Diabetologia 2019
345
3

Prevalence of diabetes among men and women in China.
Wenying Yang, Juming Lu, Jianping Weng, Weiping Jia, Linong Ji, Jianzhong Xiao, Zhongyan Shan, Jie Liu, Haoming Tian, Qiuhe Ji,[...]. N Engl J Med 2010
3

Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013.
Limin Wang, Pei Gao, Mei Zhang, Zhengjing Huang, Dudan Zhang, Qian Deng, Yichong Li, Zhenping Zhao, Xueying Qin, Danyao Jin,[...]. JAMA 2017
925
3

Global prevalence and major risk factors of diabetic retinopathy.
Joanne W Y Yau, Sophie L Rogers, Ryo Kawasaki, Ecosse L Lamoureux, Jonathan W Kowalski, Toke Bek, Shih-Jen Chen, Jacqueline M Dekker, Astrid Fletcher, Jakob Grauslund,[...]. Diabetes Care 2012
3


Dapagliflozin in Patients with Chronic Kidney Disease.
Hiddo J L Heerspink, Bergur V Stefánsson, Ricardo Correa-Rotter, Glenn M Chertow, Tom Greene, Fan-Fan Hou, Johannes F E Mann, John J V McMurray, Magnus Lindberg, Peter Rossing,[...]. N Engl J Med 2020
884
3

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
3

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann,[...]. N Engl J Med 2020
3

Diabetes mellitus, fasting glucose, and risk of cause-specific death.
Sreenivasa Rao Kondapally Seshasai, Stephen Kaptoge, Alexander Thompson, Emanuele Di Angelantonio, Pei Gao, Nadeem Sarwar, Peter H Whincup, Kenneth J Mukamal, Richard F Gillum, Ingar Holme,[...]. N Engl J Med 2011
3

Global estimates of the prevalence of diabetes for 2010 and 2030.
J E Shaw, R A Sicree, P Z Zimmet. Diabetes Res Clin Pract 2010
3

Diabetes-related morbidity and mortality in a national sample of U.S. elders.
Alain G Bertoni, Julie S Krop, Gerard F Anderson, Frederick L Brancati. Diabetes Care 2002
151
3

Role of gut microbiota in type 2 diabetes pathophysiology.
Manoj Gurung, Zhipeng Li, Hannah You, Richard Rodrigues, Donald B Jump, Andrey Morgun, Natalia Shulzhenko. EBioMedicine 2020
333
3

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
3

Diabetes: a 21st century challenge.
Paul Z Zimmet, Dianna J Magliano, William H Herman, Jonathan E Shaw. Lancet Diabetes Endocrinol 2014
417
2

Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress.
Julio C Tóbon-Velasco, Elvis Cuevas, Mónica A Torres-Ramos. CNS Neurol Disord Drug Targets 2014
133
2

Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.
C P Wilkinson, Frederick L Ferris, Ronald E Klein, Paul P Lee, Carl David Agardh, Matthew Davis, Diana Dills, Anselm Kampik, R Pararajasegaram, Juan T Verdaguer. Ophthalmology 2003
2

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
I M Stratton, E M Kohner, S J Aldington, R C Turner, R R Holman, S E Manley, D R Matthews. Diabetologia 2001
594
2

Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes.
James J Chamberlain, Andrew S Rhinehart, Charles F Shaefer, Annie Neuman. Ann Intern Med 2016
347
2

Diabetic retinopathy.
Tien Y Wong, Chui Ming Gemmy Cheung, Michael Larsen, Sanjay Sharma, Rafael Simó. Nat Rev Dis Primers 2016
364
2

Clinical end points in coronary stent trials: a case for standardized definitions.
Donald E Cutlip, Stephan Windecker, Roxana Mehran, Ashley Boam, David J Cohen, Gerrit-Anne van Es, P Gabriel Steg, Marie-angèle Morel, Laura Mauri, Pascal Vranckx,[...]. Circulation 2007
2

Outcome of sirolimus-eluting versus zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a SORT OUT III Substudy).
Michael Maeng, Lisette O Jensen, Hans-Henrik Tilsted, Anne Kaltoft, Henning Kelbaek, Ulrik Abildgaard, Anton Villadsen, Jens Aarøe, Per Thayssen, Lars R Krusell,[...]. Am J Cardiol 2011
34
5

Quantifying the effect of metformin treatment and dose on glycemic control.
Jennifer A Hirst, Andrew J Farmer, Raghib Ali, Nia W Roberts, Richard J Stevens. Diabetes Care 2012
93
2


The prevalence of comorbid depression in adults with diabetes: a meta-analysis.
R J Anderson, K E Freedland, R E Clouse, P J Lustman. Diabetes Care 2001
2

Depression and poor glycemic control: a meta-analytic review of the literature.
P J Lustman, R J Anderson, K E Freedland, M de Groot, R M Carney, R E Clouse. Diabetes Care 2000
2

Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial.
Michael Roden, Jianping Weng, Jens Eilbracht, Bruno Delafont, Gabriel Kim, Hans J Woerle, Uli C Broedl. Lancet Diabetes Endocrinol 2013
308
2

Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes.
R Chilton, I Tikkanen, C P Cannon, S Crowe, H J Woerle, U C Broedl, O E Johansen. Diabetes Obes Metab 2015
273
2


The anti-diabetic drug dapagliflozin induces vasodilation via activation of PKG and Kv channels.
Hongliang Li, Sung Eun Shin, Mi Seon Seo, Jin Ryeol An, Il-Whan Choi, Won-Kyo Jung, Amy L Firth, Dae-Sung Lee, Mi-Jin Yim, Grace Choi,[...]. Life Sci 2018
44
4

Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.
Christopher P Cannon, Richard Pratley, Samuel Dagogo-Jack, James Mancuso, Susan Huyck, Urszula Masiukiewicz, Bernard Charbonnel, Robert Frederich, Silvina Gallo, Francesco Cosentino,[...]. N Engl J Med 2020
415
2


Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in Patients With Type 2 Diabetes Mellitus.
Kristina Striepe, Agnes Jumar, Christian Ott, Marina V Karg, Markus P Schneider, Dennis Kannenkeril, Roland E Schmieder. Circulation 2017
71
2

Detection of cardiovascular autonomic neuropathy using exercise testing in patients with type 2 diabetes mellitus.
Smriti Banthia, Daniel W Bergner, Alexandru B Chicos, Jason Ng, Daniel J Pelchovitz, Haris Subacius, Alan H Kadish, Jeffrey J Goldberger. J Diabetes Complications 2013
14
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.